Department of Biomedicine, University Hospital Basel , Basel , Switzerland ; Department of Surgery, University Hospital Basel , Basel , Switzerland ; School of Life Sciences, Institute for Medical and Analytical Technologies, University of Applied Sciences Northwestern Switzerland , Muttenz , Switzerland.
Department of Biomedicine, University Hospital Basel , Basel , Switzerland ; Department of Surgery, University Hospital Basel , Basel , Switzerland.
Front Bioeng Biotechnol. 2015 Feb 2;3:10. doi: 10.3389/fbioe.2015.00010. eCollection 2015.
Secondary bone fracture healing is a physiological process that leads to functional tissue regeneration via endochondral bone formation. In vivo studies have demonstrated that early mobilization and the application of mechanical loads enhances the process of fracture healing. However, the influence of specific mechanical stimuli and particular effects during specific phases of fracture healing remain to be elucidated. In this work, we have developed and provided proof-of-concept of an in vitro human organotypic model of physiological loading of a cartilage callus, based on a novel perfused compression bioreactor (PCB) system. We then used the fracture callus model to investigate the regulatory role of dynamic mechanical loading. Our findings provide a proof-of-principle that dynamic mechanical loading applied by the PCB can enhance the maturation process of mesenchymal stromal cells toward late hypertrophic chondrocytes and the mineralization of the deposited extracellular matrix. The PCB provides a promising tool to study fracture healing and for the in vitro assessment of alternative fracture treatments based on engineered tissue grafts or pharmaceutical compounds, allowing for the reduction of animal experiments.
二次骨骨折愈合是一个生理过程,通过软骨内骨形成导致功能性组织再生。体内研究表明,早期活动和机械负荷的应用可增强骨折愈合过程。然而,特定机械刺激的影响和骨折愈合特定阶段的特殊效应仍有待阐明。在这项工作中,我们开发并提供了基于新型灌注压缩生物反应器(PCB)系统的软骨痂生理负荷体外人器官样模型的概念验证。然后,我们使用骨折痂模型来研究动态机械加载的调节作用。我们的研究结果提供了一个原理证明,即 PCB 施加的动态机械加载可以增强间充质基质细胞向晚期肥大软骨细胞的成熟过程以及沉积细胞外基质的矿化。PCB 为研究骨折愈合以及基于工程组织移植物或药物化合物的替代骨折治疗的体外评估提供了有前途的工具,可减少动物实验。